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The 5Vregion of Potato virus X (PVX) RNA containing an AC-rich single-stranded region and stem–loop 1 (SL1) has been shown to be
important for PVX replication (Miller, E.D., Plante, C.A., Kim, K.-H., Brown, J.W., Hemenway, C., 1998. Stem–loop structure in the 5V
region of potato virus X genome required for plus-strand RNA accumulation. J. Mol. Biol. 284, 591–608.). Here, we describe the
involvement of SL1 for binding to the PVX coat protein (CP) using an in vitro assembly system and various deletion mutants of the 5Vregion
of PVX RNA. Internal and 5Vterminal deletions of the 5V-nontranslated region of PVX RNAwere assessed for their effects on formation of
assembled virus-like particles (VLPs). Mutant RNAs that contain the top region of SL1 or sequences therein bound to CP to form VLPs. In
contrast, transcripts of mutants that disrupt SL1 RNA structure were unable to form VLPs. SELEX was used to further confirm the specific
RNA recognition of PVX CP using RNA transcripts containing randomized sequences of the upper portion of SL1. Wild-type (wt) sequences
along with many other sequences that resemble SL1 structure were selected after fourth and fifth rounds of SELEX (27.0% and 44.4%,
respectively). RNA transcripts from several SELEX winners that are predicted to form stable stem–loop structures very closely resembling wt
PVX SL1 VLPs. RNA transcripts not predicted to form secondary structures similar to SL1 did not form VLPs in vitro. Taken together, our
results suggest that RNA secondary structural elements within SL1 and/or sequences therein are crucial for formation of VLPs and are
required for the specific recognition by the CP subunit.
D 2005 Elsevier Inc. All rights reserved.
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Virus assembly is an essential component of the infection
cycle of all viruses. Specific recognition of viral RNA(s) by
capsid protein (CP) plays a crucial role in encapsidation of
the viral RNA genomes of plus-strand RNA viruses. Also,
for several plant RNA viruses, RNA packaging has been
shown to be essential for cell-to-cell movement (Dolja et al.,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.01.018
T Corresponding author. Fax: +1 82 2 873 2317.
E-mail address: kookkim@snu.ac.kr (K.-H. Kim).1995; Van der Vossen et al., 1994) and systemic spread
(Dolja et al., 1994; Vaewhongs and Lommel, 1995). The
sequence elements involved in the specific packaging of
viral RNAs have been identified for several viruses
including Tobacco mosaic virus (TMV; Zimmern, 1977;
Zimmern and Butler, 1977), Brome mosaic virus (BMV;
Choi and Rao, 2000, 2003), Hepatitis B virus (Junker-
Niepmann et al., 1990), Sindbis virus (Tellinghuisen et al.,
2001; Weiss et al., 1994), Human immunodeficiency virus
(HIV) (Harrich et al., 2000; Russell et al., 2003; Shubsda et
al., 2002), and the Saccharomyces cerevisiae virus L-A
(Fujimura et al., 1990).005) 83–97
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tion events in plant RNA virus movement and systemic
spread, the specific packaging signal or origin of assembly
(OAS) has not been well characterized for many of these
viruses. For a few plant RNA viruses, assembly has been
studied both in vitro and in vivo. The specific interaction
between a 69-nucleotide (nt) TMV RNA sequence including
a stem–loop structure and the TMV CP leads to the
formation of virion assembly (Butler, 1984). RNA elements
that act as specific packaging signals were also reported for
Turnip crinkle virus (Qu and Morris, 1997) and BMV
(Duggal and Hall, 1993). The in vitro assembly studies
revealed that the ionic strength and pH alter the type of
particle formed, presumably by altering RNA–protein and
protein–protein interactions. In the Cowpea chlorotic mottle
virus (CCMV), for example, under low pH (b6.0) and low
ionic strength (i = 0.2) conditions, particles assemble
without RNA, forming empty particles. At higher pH
(N7.0) and in the presence of viral RNA, RNA-containing
capsids form (Zhao et al., 1995).
PVX, the type member of the Potexvirus group, is single-
stranded, plus-sense RNA virus. The flexuous rod-shaped
particles contain a 6.4-kb genomic RNA that is capped and
polyadenylated (Bercks, 1970; Hiebert and Dougherty,Fig. 1. Schematic diagram of the PVX genome (A) and the RNA SL1 present in th
are depicted as open boxes and three subgenomic RNAs are as bold arrowed lines
loop C (LC), stem D (SD) and the tetra-loop (TL) are marked as circle and nucl1988). The PVX genome is composed of an 84 nt 5V-
nontranslated region (NTR), five open reading frames
(ORFs), and a 72-nt 3V-NTR (Fig. 1A) (Bercks, 1970;
Huisman et al., 1988; Skryabin et al., 1988). ORFs 1–5
encode viral RNA-dependent RNA polymerase (RdRp),
three polypeptides (triple gene block; TGB) involved in
virus movement, and the CP, respectively (Baulcombe et al.,
1995; Chapman et al., 1992). During PVX infection, two
major subgenomic RNAs (sgRNAs) are used to express
ORF2 and CP, respectively, while ORF3 and ORF4 of the
TGB are expressed from a third, less-abundant sgRNA
(Morozov et al., 1991; Verchot et al., 1998).
The importance of the 5Vregion of genomic RNA in the
PVX replication has been shown through several studies.
Two regions of the PVX 5V-NTR a (nt 1-41) and h (nt 42–
84), were found to enhance translational efficiency of
reporter genes in vitro (Smirnyagina et al., 1991) and in
vivo (Pooggin and Skryabin, 1992; Zelenina et al., 1992).
Multiple sequence and structural elements in the 5V-NTR of
PVX RNA affect both genomic and sgRNA synthesis and
contain multiple cis-acting regulatory signals (Kim and
Hemenway, 1996, 1997; Miller et al., 1998). A stem–loop 1
(SL1) secondary structure was found to be important for
plus-strand RNA accumulation. Miller et al. (1998) pro-e 5Vregion (B) of PVX RNA (Miller et al., 1998). Five open reading frames
. SELEX randomized sequence within RNA SL1 that occur in stem C (SC),
eotide locations are noted as lines and numbers.
Fig. 2. Purification of PVX coat protein (CP). The fusion protein was
purified from E. coli cultures using optimized conditions for solubilization,
binding to Ni2+-charged column, and elution. SDS-PAGE (A) and
immunoblot (B) analyses of eluted fractions after expression in E. coli.
Proteins were separated on 12% SDS-PAGE and either stained with
Coomassie blue (A) or transferred to nitrocellulose membrane followed by
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of the replication process, including assembly. A recent
study has indicated that the 5V region of PVX-positive-
strand RNA formed complexes with cellular proteins (Kim
et al., 2002). In addition to these crucial roles of the 5V
region for PVX replication, these cis-acting elements are
also believed to function in virus assembly. Sit et al. (1994)
showed that the first 47 nt in the 5V NTR of another
potexvirus, Papaya mosaic virus (PapMV), are sufficient
for virus-like particle (VLP) formation. Although the 5V
region of PVX is likely to contain cis-acting elements
necessary for virus assembly, such packaging signals have
not been elucidated.
In this study, we have developed an in vitro assembly
system to identify elements in the PVX 5VNTR that bind
CP subunits expressed in Escherichia coli, using viral and
transcribed RNAs containing wild-type (wt) and mutant 5V
regions. We also utilized SELEX (systematic evolution of
ligands by exponential enrichment) to identify RNA motifs
within the 5VNTR that bind CP to form VLPs. We searched
natural RNA ligands that selectively bind to the recombi-
nant CP and observed VLP formation using several selected
RNA ligands. In vitro assembly and SELEX experiments
identified CP recognition elements within the 5V NTR,
indicating that the upper portion of SL1 is required.blotting with PVX CP antiserum (B). Lane M denotes protein molecular
weight standards. Proteins from non-induced (lane 1), IPTG-induced
(lane 2), Ni column flow through (lane 3), Ni column wash (lane 4), and
eluted proteins (lane 5), and 100 ng purified PVX (lane P).Results
Expression and purification of PVX CP from E. coli
The full-length CP of PVX was cloned into the pET16b
vector for expression in E. coli as a CP fusion protein that
contains at its N-terminus a myc epitope, a glycine reside,
and 10 histidine residues (CP fusion protein). Conditions
were optimized to obtain a greater amount of the soluble
CP fusion protein by growing cells at 22 8C for 8–9 h after
addition of 1 mM IPTG to final concentration. The
expressed protein was analyzed by SDS-PAGE and
visualized by staining with Coomassie blue (Fig. 2A).
As expected, the CP fusion protein expressed in E. coli
migrated at positions in gels corresponding to a mass of
about 30 kDa (Fig. 2A). When compared with native CP
from purified virus, the CP fusion protein moved a little
slower in gels because of the tag. Un-induced E. coli did
not express CP (Fig. 2A, lane 1). The CP fusion protein
was isolated from cell lysates by two rounds of nickel
affinity column chromatography (Novagen). The CP fusion
protein passing through the column was purified at levels
up to 90% of total cell protein (Fig. 2A). The yield of
eluted fusion protein was about 250 mg/l culture. The
nature of isolated fusion protein as containing PVX CP
was determined by Western blot analysis. The immunoblot
in Fig. 2B shows that the PVX CP was expressed
abundantly in IPTG induced E. coli. After elution from
the nickel column, the sample buffer was exchanged bypassing through a PD10 column (Amersham Biosciences)
to enable use of the purified CP in assembly reactions. The
final soluble CP fusion protein used in the assembly
experiments was around 95% pure and the concentration
was about 2 mg/ml.
Assembly of VLPs in vitro with E.coli expressed PVX CP
The purified CP fusion protein was tested for in vitro
assembly with or without viral and transcribed full-length
RNAs. Assembly reactions were performed at 25 8C in
two different buffer conditions. Buffer 1 contained 10 mM
Tris–Cl, pH 8.5 and 30 mM NaCl. Buffer 2 contained 10
mM MES-NaOH, pH 6.0 (Sit et al., 1994). To monitor the
process under different conditions, assembly reactions
were examined by electron microscopy (EM). No VLPs
were observed with either buffer condition in the absence
of viral or full-length transcribed RNAs (Fig. 3A). When
viral RNA was incubated with the purified CP fusion
protein in buffer 1, VLPs or discs were observed (Fig.
3B). Similar VLPs and discs were observed with viral
RNA and with full-length transcripts using buffer 1 (Figs.
3B and 4A, respectively). However, under identical
conditions in buffer 2, VLPs were not formed (data not
shown), thus, reaction buffer 1 was used to identify
sequence requirements for initiating assembly in vitro. To
Fig. 3. Comparison of in vitro assembly by E. coli expressed PVX CP (panels A to C) and native PVX CP (panels D to F). Assembly was carried out in buffer
solution containing 10 mM Tris–HCl buffer, pH 8.5, and 30 mM NaCl (Sit et al., 1994). After 30 min pre-incubation of the CP fraction at room temperature,
1 Ag of viral or transcribed RNAs were added and incubated for an additional 2–6 h at room temperature. Panels A and D represent a reaction without RNA as
negative controls. Panels B and E and C and F represent addition of viral RNA and 5Vnt 1–203 transcripts, respectively (scale bar = 100 nm).
S.-J. Kwon et al. / Virology 334 (2005) 83–9786determine whether the recombinant CP subunits containing
the myc and His-tags affect formation of VLPs, we
compared the VLPs observed using CP subunits purified
from virions as a control experiment. Similar VLPs orFig. 4. Electron micrographs of assembly products of several RNA transcripts wit
et al. (1994). Panel A represents addition of full-length transcripts and subsequent
(C), D47–51 (D), D22–71 (E), and pGEM-SL1 chimera (F). Scale bars representdiscs were observed when the viral RNA (Fig. 3E) or full-
length transcripts (data not shown) were incubated with
native CP in buffer 1. Incubation of PVX CP alone
without any RNAs resulted in no VLP or disc (Fig. 3D).h E. coli expressed PVX CP. Assembly was carried out as described by Sit
panels include products after addition of p10 188 nt 3V-end (B), 5Vnt 1–46
100 nm.
Table 1
In vitro assembly of full and deleted transcripts of PVX cDNAwith purified
PVX coat protein from E. coli
cDNA clonesa Description Assemblyb Lengthc (nm)
wt (SpeI) Full-length +(100) 93.9 F15.25
Buffer  (0) –
P10 3Vend of PVX (0) –
wt (MunI) nt 1–46 (0) –
wt (BsiWI) nt 1–203 +(59) 46.6 F 11.5
D17 (BsiWI) Del. of nt 1–17 +(32) 40.0 F 14.61
D36 (BsiWI) Del. of nt 1–36 +(37) 37.0 F 9.17
D50 (BsiWI) Del. of nt 1–50 +(21) 35.0 F 6.0
D84 (BsiWI) Del. of nt 1–84 (0) –
D47–51 (BsiWI) Del. of nt 47–51 +(40) 34.8 F 6.02
D31–62 (BsiWI) Del. of nt 31–62 +(27) 33.6 F 8.76
D22 –71 (BsiWI) Del. of nt 22–71 (0) –
D51–95 (BsiWI) Del. of nt 51–95 (0) –
SL1-pGEM (BsaAI) Chimeric transcript d +(43) 55.2 F 5.04
a All transcripts used for assembly were digested with SpeI, MunI, BsiWI
or BsaAI from cDNA clones.
b Degree of in vitro-assembled particles using purified PVX CP expressed
in E. coli. The numbers shown in parentheses represent the percentage of
assembly efficiency for each variant RNA sequence with respect to wt full-
length transcripts.
c Average sizes of VLPs formed from each preparation.
d Chimeric transcript contains only PVX SL1 (nt 31–109) in pGEM-T Easy
Vector and digested with BsaAI located about 2.6 kb downstream from the
T7 RNA polymerase promoter generating 2.6kb chimeric RNA transcripts
in size.
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of the PVX CP did not significantly affect the formation
or the shape of VLPs in vitro.
SL1 in the PVX 5VNTR contains sequences required for in
vitro VLP formation
We have previously reported that the 5V region of PVX
RNA contains important cis-acting elements that include an
AC-rich single-stranded region and SL1 downstream. Both
regions were required for viral genomic and sg RNA
accumulation (Kim and Hemenway, 1996, 1997, 1999;
Miller et al., 1998). It has been assumed that the 5Vregion of
PVX RNA also contains a signal for virus assembly based
on a study indicating that 5V47 nt in the 5VNTR of another
potexvirus, PapMV, supported the formation of VLPs in
vitro (Sit et al., 1994). To identify the sequences within the
PVX 5VNTR that bind CP, various mutant and wt RNA
transcripts were used for in vitro assembly studies with the
purified (His)10-CP fusion protein. Three transcripts were
used for initial screening, two corresponding to either nt
1–46 (MunI) or nt 1–203 (BsiWI) of the 5Vregion, and one
corresponding to the 3V 188 nt of PVX RNA (p10). The
latter transcript from p10 failed to initiate assembly with the
purified (His)10–CP fusion protein (Fig. 4B). Formation of
VLPs was observed with RNA transcript corresponding to
nt 1–203 (Fig. 3C), while no VLP was observed with nt 1–
46 RNA (Fig. 4C). These results indicate that the first 46 nt
of 5V region and 3Vend of PVX RNA do not support VLP
formation in vitro.
To further characterize the PVX assembly signal, several
constructs that contain deletions within the 5V region were
tested for the formation of VLPs with the purified CP fusion
protein. The VLPs formed from 5V deletion mutants
appeared shorter in length of VLPs and exhibited lower
assembly efficiency than wt transcript (Table 1). In vitro
assembly reactions with transcripts from deletion clones,
including D8, D12, D17, D23, D 36, and D50, formed VLPs
suggesting that the single-stranded region located at the 5V-
end of PVX RNA did not contain essential sequence for
virus assembly (Table 1). These results indicate that an
assembly signal might reside in SL1 of PVX RNA.
Deletion of the first 84 nt (D84) and four internal deletions
(IN1, IN3, IN4 and D51–95; Kim and Hemenway, 1996)
were used to determine whether SL1 contains a signal for
virus assembly. Among those mutants, D84, IN4 and D51–
95 are predicted to completely disrupt SL1 structure, while
IN1 and IN3 are predicted to disrupt only the lower portion
of SL1 (stem A and stem B; data not shown). Interestingly,
IN1 (D47–51; Fig. 4D) and IN3 (D31–62) transcripts were
able to form VLPs. In contrast, IN4 (D22–71; Fig. 4E) and
D51–95 mutants failed to form VLPs. We thus conclude
that the SL1 located at the 5Vregion of PVX RNA (Fig. 1B),
especially the region of SL1 including nt 51–84 that
includes tetra loop (TL), stem C (SC), and stem D (SD),
contains sequence for in vitro assembly of PVX RNA. It isworth mentioning that since RNA transcripts containing just
SL1 region were assembled less efficiently than full-length
transcripts, the sequences elsewhere in the PVX genome
may play an important role for efficient assembly. Con-
firmatory evidence for SL1 as a CP binding site was
obtained with reactions containing chimeric RNA tran-
scripts consisting of PVX SL1 upstream of genetically
unrelated pGEM RNA. These transcripts were able to form
VLPs when combined with PVX CP, and the VLPs were
longer than those obtained with shorter RNA transcripts
(Fig. 4F and Table 1).
To confirm the contents of the VLPs, we performed RT-
PCR analysis using RNAs extracted from the in vitro
assembly reactions. Oligonucleotide primers specific for the
5Vregion of PVX RNAwere used for analyses. As shown in
Fig. 5A, the accumulation pattern of RT-PCR amplified
DNAs was basically similar to that of VLP formation in
vitro. Similar-sized amplified DNA fragments were
obtained from RNAs extracted from VLPs formed
with viral RNA (lane 3), full-length transcripts (wt; lane 4),
nt 1–203 (BsiWI; lane 5), IN1 (D47–51; lane 6) and pGEM-
SL1 (BsaAI; lane 8). No visible DNA bands were obtained
from reactions containing IN4 (D22–71; lane 7) and
negative controls (lanes 1 and 2). Thus, the sequences in
the TL, SC, and SD of the SL1 are associated with CP
binding and may represent an initiating signal for PVX
assembly in vitro. Detection of non-viral chimeric RNA in
virus preparations using pGEM RNA-specific oligonucleo-
tide primers further indicates that SL1 is recognized by CP
for packaging of non-viral RNAs (Fig. 5B).
Fig. 5. RT-PCR analyses of RNAs extracted from in vitro assembly
reactions. RT was carried using primer sets for detecting the 5Vregion of
PVX (A) and chimeric RNA (B). Shown in lanes 1–8 are products from
assembly reactions that included CP without RNA as negative control
(lane 1); full-length transcript without CP (lane 2); viral RNA and CP
(lane 3); full-length transcript and CP (lane 4); pMON8453-BsiWI (nt 1–
203) and CP (lane 5); IN1-BsiWI and CP (lane 6); IN4-BsiWI and CP (lane
7); and pGEM-SL1-BsaAI and CP (lane 8). Lanes M1 and M2 indicate
molecular size markers corresponding to 200 bp DNA ladder and E DNA
digested with HindIII, respectively.
Fig. 6. Schematic representation of the generation of PVX RNA aptamers
for in vitro SELEX. Randomized sequences generated for different regions
are marked in relation to the wt PVX sequence (panel A) and SL1 structure
(panel B). Regions denoted by N indicate randomized positions.
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by SELEX with PVX CP
To isolate high affinity RNA sequences and/or struc-
tures that mimic SL1 for binding to purified (His)10–CP
fusion protein, we constructed RNA transcript selection
libraries from an oligonucleotide ligand. The libraries
contained 36 random nucleotide sequences corresponding
to the region of nt 49–84 in PVX RNA for use in in vitro
SELEX analysis (Fig. 6). The RNA transcripts produced
from SELEX were subjected to successive rounds of in
vitro binding with the purified (His)10–CP fusion protein,
RT-PCR, following a regular SELEX procedure (Tuerk and
Gold, 1990). The distribution of bound and unbound
RNAs was analyzed by comparison of mobilities on a non-
denaturing polyacrylamide gel. At each round of binding
and amplification, the library RNAs were cloned and
sequenced. The sequences of bound RNAs for each round
were summarized in Table 2. The winners obtained from
bound RNAs were assessed for predicted secondary
structures in the plus-strand and minus-strand. The relative
free energy of each folded RNA for plus-strand and minus-
strand is indicated as DG(+) and DG(), respectively. The
wt sequence of TL, SC, and SD was recovered at the
second round and the frequency was increased as we
continued additional rounds (7.5%, 27.0% and 44.4% after
the 3rd, 4th and 5th rounds, respectively). Many other
selected sequences at the 5th round harbored similar RNA
sequence.We asked whether these selected RNAs share sequence
homology and/or secondary structure similar to SL1. The
RNA secondary structure folding predictions for the SELEX
RNAs were obtained with the Mfold program with default
folding parameters (Jaeger et al., 1989a, 1989b; Zuker,
1989) on the Zuker web site (http://www.bioinfo.rpi.edu/
applications/mfold). Interestingly, as we continue SELEX
rounds, most sequences of the selected population were
predicted to fold into very similar structures to wt SL1,
although individual sequences were different (Fig. 7).
To determine whether these clones obtained from
SELEX are able to bind CP and form VLPs, we selected
four clones, 5–2, 5–16, 3–4 and 3–6 (Fig. 8) based on
differences or similarities of nucleotide sequences and
predicted RNA secondary structures compared to those of
wt. RNA transcripts from these clones were analyzed for
their ability to form VLPs in vitro. As indicated in Fig. 7,
RNA transcripts from clones 5–2, 5–16 and 3–6 formed
VLPs, but transcripts from clone 3–4 did not. Also, RNAs in
5–2, 5–16 and 3–6 clones are predicted to form a stable
stem–loop structure very closely resembling that of wt (Fig.
8). In contrast, RNA sequences and the predicted RNA
secondary structures in clones 3–4 were more distantly
related to the wt. These results suggest that the stem–loop
RNA structure similar to the SL1 may also serve as a
binding site for PVX CP during assembly. Because RNA
transcripts from clones 5–2 and 5–16 that contain high
sequence and RNA structural similarity to those of wt
showed higher efficiency of VLP formation, these data
suggest that structure as well as the sequences of SL1 are
necessary for efficient assembly (Fig. 8). Altogether, these
Table 2
DNA sequences and structure stability of SELEX winners
Name Sequence (N36) No. of clones DG(+) DG(
WT TTGTTACACACCCGCTTGAAAAAGCAAGTCTGACAA 12.8 15.9
1–1 TCTTAGCGCTGTACCGCGCAATAATCTTAGGACTCG 8.4 9.8
1–2 TTGTGCTGCATACCGTCGGGTAGGGTGGCATGGTGA 17.0 6.0
1–3 TAGCCGGTCCCGCGCTTAGCATAGTGGCACGGGTGT 14.7 15.3
1–4 AAGTGCCAATGTCATCGTCACTTGCATATGGACTGT 9.0 7.6
1–5 CAGGATGGAACGACTCTTTTTGGCGGGAGCTACACG 6.4 2.6
1–6 AAGGTTGTAGTACAGGGTTGCACTGCAAGAGTTGGT 10.0 9.4
1–7 ATGAGTTTTGGACCAACTGCTCATTCTACAAGATAG 2 6.7 7.0
1–8 ATGTGTTGGTGACTTGGGCTCCGGGTTTAGCCCTGG 10.7 10.4
1–9 CCGTTTACTTTGGTCGTAGTGGTGACTGGCCTTAAT 7.4 8.2
1–10 CTTTACCACTAGCGCCCGGCCAGTGCGGTGGACTAG 14.5 13.7
1–11 TTGGCATCTCTTTCCATTAACTTCGGCCGTGGTTTT 4.9 3.4
1–12 TTACCCTCTAAAATGTAAAAAAGTGCTTTTCTAGTT 0.5 3.7
1–13 CAGGTCGGTTGATTTGTATTTTGCGGAAGACCGTGC 10.3 7.3
1–14 ATGCATTGTGCATAAATGACACGGACGGTCTCTGGT 7.3 7.1
1–15 TTTGCTGAGTAATGGCATAGTGTGCTCCAACGTGCG 8.3 3.7
1–16 CGCTCAGTGCCCTCATTTAGGTCGCGGTAAGGAAGG 6.0 5.5
1–17 TGGGGAATCTTGGGCCTGGGTCATCTAAGGACCGAA 8.6 6.8
1–18 TTTACATTTTTTTACGGGTTGTAAAACTCAGAGAGG 7.0 2.5
1–19 TTTTCACCGAATGACTCTGCATCTGTGTTAAGGGTT 8.0 3.1
1–20 TTGCATTATTCCTTTCCGGTGTCGCCTGCGGGACAT 7.1 5.9
1–21 CTTTGTGTACCGCCACCTTCAACCCAGCTATTGTAT 4.3 9.9
1–22 CGGTGTACACGGGGCCGGGGACCGCGGAATCGGCGG 11.3 8.6
1–23 CGTCTAAAAATTCGACCGAAGACGCAGGTGGTATTA 5.5 8.6
1–24 CTTAACGCTTCCGGTAGGGTGGCTTTCCTAGTGTAA 10.0 4.4
1–25 TTTCTATACTGTTCATTGGTTGCGCCAGCATAATGG 10.3 10.0
1–26 ATGTTGTAAAAAGGAGGTTCTCTGGGCGGTTCTTCT 5.0 1.5
1–27 AGTAGGCTTGATTATGTGGTTGGCGCCCGCACTAGC 8.5 8.0
1–28 CTTATCGTTGTGTCATTGGATTAGATTGCCTCGATT 5.1 7.9
1–29 TTTGTGCCAATTTGGGCTGGGTTGGGTGCCCAGAAC 17.1 14.4
1–30 ACCGGCTTATTCTTCGTTTATCTTACGGCAGGACGG 7.2 4.3
1–31 CCGATCTGGTAACAGGTGGGTCGGGCGGAGTCGAGA 13.9 9.4
1–32 ACACCAAGGTAGCTGCGATTCAGGATCAGCAGTTGC 15.3 9.3
1–33 TTACGGCCGCCCACGGACCTGGGCCTAAGCCTCTTT 12.3 15.6
2–1 ATGTGTTGGTGACTTGGGCTCCGGGTTTAGCCCTGG 10.7 10.4
2–2 ATAACTATATAGCATAATACTTGTTTGCGTTACTGT 5.0 4.0
2–3 GTCAGCAAATGGTTCTGTCTGTCCACGCCGACAGTG 7.6 11.0
2–4 TTTTGGCTCCACATGGATCAGAGTCCTGTGGCATGT 11.4 10.6
2–5 TTGCCATGCTGTGGACCTTCCCTATGCTACTGATGT 10.0 9.4
2–6 TCGCCATACTTTTTTGTTTGGCTTATTGGTTGTGAC 11.1 10.8
2–7 TTGTTACACACCCGCTTGAAAAAGCAAGTCTGACAA 2 12.8 15.9
2–8 CACAGGTAGGATAACAGATCTTGTTGTTGTCGGTGA 7.7 6.2
2–9 AGGTGAGGGACCTCGTTCCATATCTCAACGTTTGCC 8.1 6.7
2–10 TCAATGTTTGCTTAGGTGACGGCAGTGAGATTCTAC 4.3 1.6
2–11 CCAACCCCTGACGTCGCTTGCTGGTTGCGTTGATGC 9.6 9.7
2–12 GGATACCTGTGTTACATCATGTACTTCAGGATGGTA 7.8 8.6
2–13 ACCAGTTCCTTAATAGCATAAATTTCGTAACTGGCT 7.0 10.7
2–14 TCATCGGTACGATTCTCCTTTAGAACTTACCCGTCG 7.8 11.2
2–15 TAACCGTTCGGGTGATTGACTTAGATTTGCCGGGTC 2 8.7 8.6
2–16 CACGCAGATCCTAATTACCATGTATTTCAGTGCTTG 4.3 5.3
2–17 GTGACAGTCAATATTAAGTTGGTACGGTTTTATCTG 3.8 1.5
2–18 ATTGAATGTTCACTTCAGTAAGAGTGTGTTATTCGA 10.9 5.3
2–19 CTTTGAATCCGGGGGAAACGATGGTTACCAAGACTG 4.4 4.6
2–20 TTATCCTTAAGCTTCCGGTGAGATAGCGCGGGTTAG 9.1 6.5
2–21 TCGCACCTTTTCCCACGCCCAGCTTAACGTACGCTT 4.1 7.7
2–22 TCAGCCGAAATTACATTCTGGCTGTTGGGATGACCA 13.7 13.5
2–23 CTATAGACTTATTAGTAAATGTTCGTTTTGCTTTTC 3.4 2.2
2–24 CTTGACGATGGTCGGAGATATTTGGACACACTAAAA 5.7 3.0
2–25 TCAAATACTCTCTATCCCTTAAAGTGTTTGTCGGGC 7.5 7.3
2–26 CAGCACAGCACCTCTGTCGGTCCCCNCGTGCGATGC 8.7 13.1
2–27 AAAGGTCTAGAAAATTATTCCTTGGGAAGGCCGCGC 7.0 6.2
(continued on next page
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Name Sequence (N36) No. of clones DG(+) DG()
2–28 GCAATTACGGTACGGCACGACATCCTCTCGTGGCCG 10.3 10.1
2–29 CTATGAATTGCATGAGATGAGCTTTGCTTTAGGGTA 5.9 1.4
2–30 GTACTCTTGTGTTAAACTCCTTATGAGACTCTGTGT 6.2 4.3
2–31 GTGTCCTTTGGATTCAAGCGATGTAGTTGCTCTCC 8.3 6.9
2–32 ATGCCAAGTGGATCGTGGCTCGTGGCCGACTTGGGG 12.4 10.7
2–33 TTTATGCCCATTTGTGGTTGAGGTGGGTATACCAGG 12.9 6.7
2–34 CTAACTATCTCCGTTCGGTTACAACGCTGTAAGCTC 5.1 6.7
2–35 TCCACGTACTGCATTGCGTGCGAACGGTTCACCTGG 12.5 11.2
2–36 ATTCACGGAGGCCGTTACCGCAGTGCAGTGTTCTCG 6.7 7.6
2–37 TATTGTCCACCCGACATTAGCTGGAATTAAGTGTTG 6.5 6.0
3–1 TCTCTGTTACATGGTTTCGGATACCATTTTACGCGA 8.3 8.8
3–2 TTGTTACACACCCGATTGAAAAAGCGAGTCTGACAG 8.6 10.1
3–3 AACCGTCCGGTTGAGTGTCATATGGACAGTGAGTAT 8.1 9.5
3–4 TGATGGTATTGGAGCCACCTAAAGGGACGTTTTCGG 10.7 11.9
3–5 TTGTTACACACCCGCTTGAAAAAGCAAGTCTGACAA 3 12.8 15.9
3–6 CCCCACCGACCGATGATCTTGAGCGTACATCGCGGG 9.6 12.7
3–7 TCGGTCGCTAACATGTACTATATCGCTTAGGCTCTG 6.7 2.7
3–8 CTAACATTCTCTTTGACGGTAATCGGAATGTGGATC 7.7 5.7
3–9 TATTGCATCACGTGATACGTTCACACCTTTATGCGT 7.7 10.5
3–10 TCGTGTGAGCAGGAGTTAAATCACCCGATCACTCGT 12.0 13.0
3–11 TAGACGAGAACACGAATTGCTGCGTGTGGTAACCGT 6.8 5.7
3–12 TTGGTAGCGCAGGCTTTGCTCCCAATTCGAATGGTG 8.5 8.5
3–13 TTTCGCATGACGACCGAGGAAGTGTTAGAGGTTTAA 4.7 3.6
3–14 TTCGTGCTGGACCCTCTGCTGTTACACCGTCGCGGG 10.1 5.9
3–15 TACTACTTAGGTTTGATACGTGTATGCTATTGGTGC 6.7 4.0
3–16 AGTCGAGGCTGCTACTTGTAGTACGTGCGAGCACAC 10.0 6.7
3–17 TATCCATTGATGTGCGCATATAGATCGTCAGGTGTG 6.9 4.2
3–18 TCGAGTGCGAGCCCCGCAAGGTGAGTGTGCCTCGAT 18.6 13.6
3–19 TGTCCTGGGGTTCTTGCTGTGGGGGTAGGACGGTGT 9.4 5.1
3–20 TCCCGATAGACTGGCATAGTTATGCATTGTGTCGAT 8.6 7.5
3–21 AATACTCAACCACGTTGTGATTTTCGGCAGTGATGG 6.4 5.4
3–22 ATGAGAAAGGATCGACGTTATCGCCTCCGTTGTCAC 10.0 12.4
3–23 ATAGATTTTATTTGAACTATGGGCGATGGCAGGCC 9.8 9.0
3–24 CTAAATACGCTTCAGCTTTGCTTGGACGGTTTCGGC 6.6 7.6
3–25 GCGATTTAGTCCAAGTCGTGATCGGAAACACGGATA 8.4 6.0
3–26 TCGGTGCAAGACGTCGCTTAACGGCTGCGTCAGGAG 10.9 8.3
3–27 ATGCCGGATGCCTGCAAGGGGTACATTCATCCCAGG 11.8 13.6
3–28 CTTTTCGATTGTCTCCGTCTGCGTTGATTTCTCGTT 6.4 4.1
3–29 TTGTCCTACAAGGGTCGGTACCGGAAGTAAGCGGAG 8.1 8.3
3–30 ATACCCTGGTCCCTGACGTTAGCTGTGGAACCGTGT 8.4 13.0
3–31 CTGTGCTACCTGGTGCCCGGTACCTCGTGTGCACTA 15.7 9.8
3–32 CTGGTGTCATGTAGGAAGGGGTAAGCCTTACCGAAC 14.0 9.9
3–33 ATTCTGGATGTGAGAATCAGATTAAGCTAGGATTTG 11.4 2.3
3–34 CAGTATCGATCCTTACCTAGTAACTCGTAGCGTGTT 4.4 3.5
3–35 CACGACATTCAGCAGGACGATGAATATAGCGCGGAC 3.2 9.6
3–36 TTTGGATGGCTTGTTCCTCGGGATAGTTACGGAACC 7.1 6.7
3–37 TACAGATGCTAATGTCTAAGCTGGAAGTCTTACTGG 5.6 5.7
3–38 ATTTGGGGTGCTCCGGCAGTTCACCGTTCGTAGGGT 8.6 5.5
4–1 TTGTTACACACCCGCTTGAAAAAGCAAGTCTGACAA 10 12.8 15.9
4–2 TGTTCATGAGTCAACGGGGTTTGAGAGGCCGCGTGG 10.8 3.8
4–3 TTGTTACACACCCGCTTGAAAAAGCGAGTCTGACAA 15.5 17.9
4–4 CACACCGGGCATTACCGAGGATGTTTTCTTGTGGTG 12.3 7.1
4–5 TCTTTAACCCCGAAGCTTGTGCAGGCAATCGCTGCC 8.6 7.5
4–6 TGTCCCAGGTGGTGTAGGCAGGTAGTGGTGGTGTGG 6.0 2.9
4–7 TTTTTCATTTTATTTGTCGTTTGTTGCTTTTGGTCA 2.2 0.3
4–8 TAAGATAGTGAGCTAGGGACGGTACATGGGTGGTAT 5.8 0.1
4–9 CTACAATGTGTGCTATGTGTGTTCGTCTAGAGGCGA 7.6 2.9
4–10 TCCTGAACCGTTGCGTAGTGATGGACGTTGGGGATG 12.8 5.0
4–11 TAAGCGGCATGTGTAGAGAGGCGGTTGGCTGGGCTG 7.7 2.4
4–12 TAACGTGTATGTGGTCTGGTACGTGGGGTGAGGGGC 6.4 1.1
4–13 TTCTCGTCACCCTGTTAGCACGGATCGGGAGGGCAT 8.9 6.9
4–14 CTGATGGACGAGTGCACCCGAAGTGCGTGCCGGGGC 12.1 11.4
4–15 ACTAGGACGGTAGCCGTGCCGTTCGTTTACGCGTAG 10.8 9.0
4–16 TCCTGAACCGTTGCGTAGGGATGGACGTTGGGGATG 7 12.0 5.7
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4–17 TTTCAGGTCACTGGCCCCTCTGAGTGGGTGCGGTGA 14.5 9.8
4–18 CCGCACCAAACTCATCGGACCGACGAGGATGGGGCA 13.6 20.0
4–19 TACTCTGAGCTGGCTGATTGTAGACGATTGTTGTGG 4.0 1.4
4–20 CATCTTGCGCGCACTGGGGGACCTATGGTCAGTCCC 11.7 12.6
4–21 CTCTCGCGGCTCTTTCTGTTGGGAAGTCGTTGCGCT 12.3 4.7
4–22 CACGTGCGCAGATCGCCGAGCGTGCCAGTGTTACGG 11.4 11.4
5–1 CATGCCGGCCTGGACTGCGAGTTTTTGTGTTGCTAC 6.9 4.5
5–2 TTGTTACACACCCGCTTGAAAAAGCAAGTCTGACAA 16 12.8 15.9
5–3 ACAAATACGAGCGAAACCCTGGAGGCTGTGCGTAAG 4.6 6.2
5–4 TTGTCCTACAAGGGTCGGTACCGGAAGTAAGCGGAG 8.1 8.3
5–5 CAACATAGAGGAATCGTATACGGTGGGTCTAGGGGG 7.9 3.5
5–6 TCTTACCCGTGTTAAGAAGCGTAAATGTGTTTGA 3.0 2.9
5–7 TCCTGAACCGTTGCGTATGGATGGACGTTGGGGATG 12.0 4.8
5–8 ACGTAGGTTCCTCGAGGTAGTGGTGCGCCGGTGATG 7.0 5.6
5–9 TTACCGTTGGACGTATGGCCGGCGAGTGTCCGGGAC 11.3 7.3
5–10 CGATTCCATTTCTAGTGGGCCTCGGTTAGTGAGGGG 9.7 7.6
5–11 CACTCATCCCAGGCGGTTGACCGCGTGGTCTCGTAG 13.8 14.6
5–12 TCAGCCTACGTTGAGGTGCCGTCAGGATTGTGGGTC 9.1 6.5
5–13 TACCTGATCGTAGGGGGCCGCAGGGGGGCTAGGGGG 9.4 5.2
5–14 CCTAGCCATTTGAGGTTTACTAGGGTGCGGCGTCGG 15.8 7.4
5–15 CTTTCGTGACGTAAAGGCGCGTTAGGTAGTCCCAGC 6.9 6.4
5–16 TTGTTACACACCCGATTGAAAAAGCGAGTCTGACAG 2 8.6 10.1
5–17 TTGTTACACACACGCTGAAAAAGCAAGTCTGACAA 2 10.4 11.3
5–18 TTGTTGCACACCCGCTTGAAAAAGCAAGTCTGACAA 11.5 15.9
5–19 TCCTGAACCGTTGCGTAGGGATGGTCGTTGGGGATG 11.1 6.1
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contain a binding signal for the PVX CP and thus may serve
as an OAS for PVX.Discussion
To determine if the 5V region of PVX RNA contains a
binding site for CP, we developed an in vitro assembly system
using E. coli expressed PVX CP protein and showed the
formation of VLPs with RNA transcripts containing SL1
located at the 5Vregion of PVX RNA. Electron microscopy
revealed the formation of VLPs both from purified viral RNA
and full-length transcripts. Three constructs, nt 1–46, 1–203
and p10, identified a binding site in the 5V region of viral
RNA, but not in the 3Vregion. To quantitatively analyze VLP
formation in vitro, efficiency of in vitro assembly was
calculated compared to that of full-length transcripts. RNA
transcripts corresponding to nt 1–203 of PVX RNA showed
relatively high efficiency (56%). The formation of VLPs from
all mutant transcripts that contain top region (SC, LC, SD,
and TL) of SL1 (mutant clones D8, D17, D36, D50 and IN1)
and the failure or poor VLP formation from deletion mutants
that do not contain the upper portion of SL1 (D84, IN4 and
D51–95) indicate that this region of SL1 (or sequences)
function in assembly. Small sizes of VLPs were observed in
all mutant transcripts used as well as the construct containing
the 5Vnt 1–203, compared to those observed in full-length
transcripts or viral RNA and the efficiency of in vitro
assembly was also lower (21–40%). Similarly, when tran-
scripts for 5V nt 1–203 were incubated with CP subunitsisolated from purified virions, small sizes of VLPs were also
observed (Fig. 3F). These results suggest that PVX assembly
is triggered by the SL1, but other sequences of PVX RNA
and/or another factors may be required to make VLPs
efficiently. VLP formation from chimeric RNA transcripts
containing the SL1 region (2.6 kb RNA transcript from
pGEM-SL1) further supports a specific interaction between
PVX CP and the SL1 region. Formation of VLPs with
potexvirus CP expressed in E. coli and chimeric PVX RNAs
provides us a new tool for identification of CP factors or
domains required for virion assembly.
Altogether, these results indicated that RNA sequence
and/or structure of SL1 plays key role in initiating VLP
formation, and may function as the OAS for PVX in vivo.
The GAAATL, SD, LC and SC within SL1 were reported to
play important roles for PVX replication and RNA
accumulation in protoplast (Miller et al., 1998, 1999).
Miller et al. (1998) also suggested that SL1 may function in
assembly and translation of the RdRp. RNA stem–loop
structures of viral RNAs have been characterized as OAS
elements (Choi and Rao, 2003; Mansky and Gajary, 2002;
Turner et al., 1988). For TMV, the OAS is an RNA stem–
loop structure located between 900 and 1300 nucleotides
from the 3Vterminus of TMV RNA (Butler, 1984). Since the
OAS of TMV is located near the 3V terminus of the RNA,
encapsidation of TMV RNA has been shown as a bi-
directional process (Fukuda et al., 1980; Ohno et al., 1977;
Zimmern, 1977; Zimmern and Wilson, 1976). Site-directed
and deletion mutation analyses revealed the sequence
AAGAAGUCG, located at the loop 1 of TMV OAS, as
the strong binding site for TMV CP (Turner et al., 1986).
Fig. 7. Predicted RNA stem–loop structures of obtained RNA sequences after the 5th rounds of selection. Secondary structures of selected sequences were
predicted by Zuker program (http://www.bioinfo.rpi.edu/applications/mfold).
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RNA like structure postulated to function as a nucleating
element (NE) for CP subunits (Choi et al., 2002) and a 187-
nt cis-acting element located in the movement protein gene
of BMV RNA serves as position-dependent packaging
element (PE) (Choi and Rao, 2003). Efficient incorporation
of non-viral chimeric RNAs containing NE and PE into
VLPs indicated that these two RNA elements were
sufficient to direct packaging (Choi and Rao, 2003). Since
we obtained low efficiencies of PVX VLP formation with
RNAs containing just SL1 compared to that with full-length
transcripts, other sequences of PVX RNA that serve like PE
in BMV packaging may be required. It will be interesting to
determine if other sequences and/or factors are required for
efficient PVX assembly in vitro and if these are also
necessary for assembly in vivo.
In contrast to TMV and BMV assembly, the assembly of
potexviruses and potyviruses is thought to initiate at or close
to the 5V-end of the RNA. It has been shown that the ntsequence at the 5V-end (especially nt 38 to nt 47) of PapMV
was necessary for CP binding and assembly of VLPs in
vitro (Sit et al., 1994). This sequence is rich in adenosine
and cytidine residues, poor in uridine residues and lacking
any discernable RNA secondary structure. Interestingly,
PVX also contains sequences rich in adenosine and cytidine
residues at the 5V-end of the RNA (nt 1–41). This region,
however, was not required for the initiation of PVX
assembly, since deletions in the 5V proximal region of the
PVX RNA had no or mild effects on the formation of VLPs
(Table 1). Since the OAS is located at the 5V region,
initiation of assembly probably proceeds in the 5V to 3V
direction by the addition of CP subunits until the entire
genome was packaged (Lok and AbouHaidar, 1986). This
model predicts that small RNAs would make incomplete
short virions while larger RNAs would form longer virions.
Our results showed that small RNA transcripts containing
the SL1 formed small VLPs, whereas chimeric RNA formed
longer VLPs, although less efficiently than that of full-
Fig. 8. Predicted RNA stem–loop structures of selected SELEX winners and their efficiencies of VLP formation. The marks and numbers shown in parentheses
bottom of structure for each selected clones represent the degree of assembly and percentage of assembly efficiency with respect to full-length and
corresponding length of wt transcript controls, respectively.
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it is also worth mentioning that sizes of VLPs obtained from
transcribed full-length RNAs were shorter than that from
viral RNA (Fig. 3). These findings suggest that the genome
size and nature are limiting factors for determining the
length of virions for PVX and for other rod or flexuous rod-
shaped viruses that contain the OAS near the termini of the
genome.
For many viruses, CP subunits isolated from purified
virions were used for in vitro assembly (Choi and Rao,
2003; Wengler et al., 1984). The use of CP from virion,
however, can be problematic for use in an assembly system
due to mutant viruses present in the purified virus
preparation. To circumvent these restrictions, a prokaryotic
expression system for production and purification of CP was
developed and used for in vitro assembly of several viruses
(Tellinghuisen et al., 1999, 2001; Zhao et al., 1995).
Observation of VLPs using recombinant CP subunits
confirms that PVX CP extensions containing myc and
His-tags did not significantly interfere with VLP formation.
VLP formation with small oligopeptide extensions to the CP
(Porta et al., 1994; Sugiyama et al., 1995) and with a foreign
protein that are at least as large as the PVX CP (Santa Cruz
et al., 1996) have also been described. The ability of PVX to
assemble into VLP with E. coli expressed recombinant CP
subunits enables the high-level expression of CPs contain-
ing a variety of mutations and offers a rapid means by which
to study plant RNA virus assembly.
The SELEX RNA-based strategy has been shown to be
highly effective in determining target RNA sequences
involved in interacting with specific protein (Ellington
and Szostak, 1990). We employed SELEX RNA aptamers
to the target RNA sequence(s) that bind to PVX CP. The wt
sequences and thus exact SL1 structure was obtained usingthe randomized sequence of TL, SC and SD in SL1 from
the second round of SELEX processes and the proportion
of wt sequences were significantly increased over each
round. Interestingly, many SELEX winners obtained at
round 4 and 5 that contain sequences different from wt
were able to form very stable RNA secondary structures
similar to SL1, and the proportion of these RNAs was also
significantly increased over each round. VLP formation in
our system, although less efficient than that of full-length
transcripts, also suggests that RNA secondary structure
resembling wt SL1 may serve as the OAS for PVX
assembly.
In this study, analyses of the 5Vregion of PVX RNA for
VLP formation and selection of RNA aptamers that
specifically bind to CP reveal that the sequences and/or
structures in SL1 are sufficient to assemble the RNAs into
VLPs. How SL1 (or sequences therein) of PVX RNA
functions in RNA replication and in initiation of virion
assembly is the subject of future investigation. Further
characterization of the role of SL1 in assembly and the
potential involvement of host factor(s) in this process is
currently underway.Materials and methods
Virus purification, viral RNA extraction and RNA analysis
by RT-PCR
PVX virus was isolated from Nicotiana benthamiana
plants as described by Erickson and Bancroft (1978). Viral
RNA was extracted from purified virus (1–2 mg/ml) with
phenol/chloroform after treatment of 0.1% SDS to 200 Al
of virus and heat treatment at 40 8C for 10 min. The RNA
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agarose gel. RNAs extracted from purified virus or in vitro
assembled virion preparations were analyzed by RT-PCR.
Three different oligonucleotide primer sets were designed
and used for RT-PCR, two specific primer sets for detecting
the PVX 5V region (PVX-5pr1: 5V-GAAAACTAAACCA-
TACAC-3V; PVX-5pr2: 5V-AAACCCACCACGCCCAA-3V
corresponding to nt 1–18 and nt 32–47 of PVX RNA,
respectively; PVX-3pr1: 5V-ATGATGGGACGAATATTTC-
3V; PVX PVX-3pr12: 5V-AAACCTCGCGCACTTTGG-3V
complementary to nt 161–176 and nt 89–106, respectively)
and one set for detecting chimeric RNA (PVX-5pr2 and
pGEM-3pr: 5V-CCTCGCTCTGCTAATCCTG-3V comple-
mentary to nt 923–944 of pGEM-T Easy Vector). Reverse
transcription (RT) was carried out in a final 20 Al volume
obtained by adding 12 Al of a RT reaction mix (2 Al 10RT
buffer, 4 Al 2.5 mM dNTP mix, 1 Al Mu-MLV Reverse
transcriptase (NEB), and made up to volume with DEPC-
H2O). RT was carried out at 40 8C for 60 min. When RT
was completed, 50 Al of a PCR reaction mix (3 Al 2.5 mM
dNTP mix, 5 Al 10 PCR buffer, 1 Al specific virus
primers (25 pmol each), and 0.5 Al Taq DNA polymerase
(TaKaRa)) was added. Amplification was carried out for 35
cycles, 80 s at 93.5 8C for denaturation, 80 s at 55 8C for
annealing, and 80 s at 72 8C for synthesis, followed by 10
min at 72 8C.
In vitro transcription
The unique restriction enzyme sites MunI, BsiWI, NcoI,
and SpeI located at 46, 203, 708, and at 3V-end wt PVX
cDNA, respectively, were used to generated PVX RNA
transcripts for in vitro assembly. The deletion mutant clones
in the 5VNTR, that is, D8, D12, D17, D23, D36, D50, D76,
D84, IN1, IN3 and IN4 (Kim and Hemenway, 1996), and
additional deletion mutant, D51–95, deleting nt 51–95 from
the 5Vend of PVX genomic RNA were also digested with
BsiWI and used to generate mutated transcripts. Plasmid
p10 (Miller and Hemenway, unpublished data), which
contains only 188 nt of the 3V region of PVX RNA, was
used to generate 3VRNA transcripts.
To determine whether a chimeric RNA sequence
containing SL1 can bind the PVX CP and initiate assembly,
clone pGEM-SL1, which contains only PVX SL1 (nt 31–
109) in pGEM-T Easy Vector (Promega), was constructed
and used for in vitro assembly. As the size of the RNA is
known to influence virion assembly (Qu and Morris, 1997;
Schneemann and Marshall, 1998), pGEM-SL1 was digested
with BsaAI located about 2.6 kb downstream from the T7
RNA polymerase promoter and used to generate 2.6 kb
chimeric RNA transcripts in size. After digestion with each
restriction enzyme, RNA transcripts were generated from
linearized cDNA templates using T7 RNA polymerase as
described by Kim and Hemenway (1996). Integrities and
relative concentrations of purified transcripts were analyzed
by agarose gel electrophoresis at 4 8C.Clone construction, expression, and purification of PVX CP
from E. coli
PVX CP gene was cloned and expressed in E. coli
using pET vector system (Novagen). p55 was constructed
by insertion of an NdeI site at the AUG initiation codon of
the CP coding sequence in the parent plasmid, pMON8453
(Hemenway et al., 1990), which contains the entire PVX
cDNA. Further modifications to p55 included an in-frame
insertion of a c-myc epitope and (Gly)6 downstream of the
initiator AUG (and NdeI site) to yield clone p56. Finally
the NdeI and BamHI fragment from p56 that includes the
entire CP coding region was inserted into the E. coli
expression vector, pET16b, which was also digested with
NdeI and BamHI. The resulting CP expression clone p58
contains (His)10 tag-AUG-c-myc-(Gly)6 fused to the N-
terminus of PVX CP. Expression of full-length PVX CP in
E. coli strain BL21 (DE3) was carried out as previously
reported (Grodberg and Dunn, 1988; Studier and Moffatt,
1986; Studier et al., 1990) with minor modification.
Briefly, transformed cells were grown overnight at 37 8C
in LB medium supplemented with 100 Ag/ml of ampicillin
and used to inoculate (1/50; vol/vol) LB medium. The
culture was grown 5–6 h at 28 8C and protein expression
was induced by the addition of isopropyl-h-d-thiogalacto-
pyranoside (IPTG) to a final concentration of 1 mM. After
8 h at 22 8C with shaking, the cell were immediately
chilled on ice, collected by centrifugation, resuspended in
binding buffer (20 mM Tris–HCl, pH 7.9, 500 mM NaCl,
and 5 mM imidaziol) for Ni2+ affinity column, and lysed
by sonication after treatment of 100 Ag lysozyme at 30 8C
for 20 min (Zhao et al., 1995). Cell lysates were clarified
by centrifugation and the recombinant protein was purified
from the soluble fraction by affinity chromatography using
a Ni2+-chelating column (Novagen). Purified proteins were
first analyzed by SDS-PAGE and then applied to a PD10
column (Amersham Biosciences) to exchange the buffer
for assembly reaction. Protein concentration was deter-
mined by the Bradford analysis (Bio-Rad). Detection of
PVX CP was conducted by Western blotting (Kim and
Hemenway, 1996, 1999); the blots were probed with
antiserum prepared against purified PVX, and products
were visualized using a Biotin/Streptavidin kit (Amersham
Biosciences).
Preparation of dissociated CP subunits
PVX CP was dissociated from purified virions by
dialyzing at 4 8C for 24 h against a buffer containing 500
mM CaCl2, 50 mM Tris–Cl, pH 7.5, 1 mM EDTA, 1 mM
DTT, and 0.5 mM PMSF. Following a low-speed centrifu-
gation at 12,000  g for 30 min, the supernatant was
subjected to 180,000  g for 2 h to remove intact virions.
Dissociated CP was dialyzed at 4 8C for 24 h against an
assembly buffer containing 10 mM Tris–HCl, pH 8.5 and 30
mM NaCl. The CP was concentrated using Centricon-
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concentration by Bradford analysis (Bio-Rad).
In vitro assembly and electron microscopy
Assembly reactions with viral and transcribed RNAs
were performed using a protocol similar to that described
by Sit et al. (1994). Briefly, approximately 50 Ag of
recombinant CP were incubated at room temperature in 50
Al reaction volumes containing buffer 1 (10 mM Tris–
HCl, pH 8.5; 30 mM NaCl) or buffer 2 (10 mM MES-
NaOH, pH 6.0). After 30 min pre-incubation at room
temperature, the viral or transcribed RNAs (1 Ag) were
added and incubated for additional 2–6 h at room
temperature. Each in vitro assembled VLP preparation
was purified through linear sucrose density gradient (10 to
40%) and examined with a JEOL transmission electron
microscope (JEM 1010, Japan) by examining the neg-
atively stained (1% uranyl acetate) preparations at a
magnification of 60,000. The average number of VLPs
within an area of 10 nm2 from at least 5 individual grid
areas was used to determine assembly efficiencies of each
RNA tested. Average number of VLPs observed with wt
transcripts was considered as the reference for 100%
assembly efficiency. Genomic PVX RNA and DEPC-H2O
were used as positive control and negative control,
respectively.
Construction of RNA selection libraries, SELEX and
RNA-binding
The SELEX procedure was performed as described by
Tuerk and Gold (1990). Synthesized RNA libraries were
generated using synthetic oligonucleotides (5V-TAATAC-
GACTCACTATAGACCAAACCCACCACGCCCAA-N36-
ATGGCCAAAGTGCGCG-AGGTT-3V; Fig. 6 panels A and
B). Two flanking sequences were used as annealing sites for
generating double-stranded transcription templates by PCR
amplification with T7 primer (5V-TAATACGACTCACTA-
TAGACCAAACCCACCACGCC-3V) that contains T7
RNA polymerase promoter at the 5V end and a reverse
primer (5V-GGAATTCAACCTCGCGCACTTTGGCCAT-
3V) that contain EcoRI site (underlined). RNA was prepared
from this template using T7 RNA polymerase as describe
previously (Kim and Hemenway, 1996, 1999), and body
labeled with [a-32P] CTP (Amersham Biosciences).
The SELEX RNA probes synthesized in the presence of
with [a-32P] CTP were incubated with 5 Ag of purified CP
on ice for 10 min in binding buffer as described previously
(Kim et al., 2002). The reaction mixtures were separated on
5% non-denaturing polyacrylamide gels and analyzed with
BAS-2500 (Fuji). Protein-bound RNA was separated from
free RNA by excision from the gel, eluted in buffer
containing 0.5 M ammonium acetate, 1 mM EDTA and
0.1% SDS, and then used for reverse transcription. The
resultant DNAwas amplified by PCR and used as a templatefor subsequent cycles. After 5 cycles of enrichment, the
PCR products from each round were cloned into pGEM-T
Easy Vector (Promega) and subsequently sequenced.Acknowledgments
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